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Infection of man with Schistosoma species of trematode parasite causes marked chronic
morbidity. Individuals that become infected with Schistosomes may develop a spectrum
of pathology ranging from mild cercarial dermatitis to severe tissue inflammation, in partic-
ular within the liver and intestines, which can lead to life threatening hepatosplenomegaly.
It is well established that the etiopathology during schistosomiasis is primarily due to an
excessive or unregulated inflammatory response to the parasite, in particular to eggs that
become trapped in various tissue.The eggs forms the foci of a classical type 2 granuloma-
tous inflammation, characterized by an eosinophil-rich, CD4+T helper (Th) 2 cell dominated
infiltrate with additional infiltration of alternatively activated macrophages (M2). Indeed the
sequela of the type 2 perioval granuloma is marked fibroblast infiltration and development
of fibrosis. Paradoxically, while the granuloma is the cause of pathology it also can afford
some protection, whereby the granuloma minimizes collateral tissue damage in the liver
and intestines. Furthermore, the parasite is exquisitely reliant on the host to mount a gran-
ulomatous reaction to the eggs as this inflammatory response facilitates the successful
excretion of the eggs from the host. In this focused review we will address the conundrum
of the S. mansoni granuloma acting as both friend and foe in inflammation during infection.
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Schistosomiasis is a major chronic disease of humans in endemic
regions. The schistosome species of major medical relevance to
man are Schistosoma mansoni, S. haematobium, and S. japon-
icum. In this review we will focus on granulomatous inflammation
following S. mansoni infection. Whilst in the majority of cases
people infected with S. mansoni are relatively asymptomatic, or
show restricted morbidity associated with intestinal inflamma-
tion and fibrosis, a minority of infected individuals develop a
severe hepatosplenic schistosomiasis (HS). HS is characterized
by hepatic fibrosis, hepatosplenomegaly, and portal hypertension,
and can result in death in the absence of medical attention. A cen-
tral feature of the pathology associated with S. mansoni infection
is the development of granulomatous inflammation around para-
site eggs that become trapped in tissue, in particular the liver and
intestines. The host’s immune response generated against parasite
antigens plays a critical role in both dictating the severity of tis-
sue inflammation and associated disease. Paradoxically, the host
immune response to the parasite also facilitates parasite replica-
tion and survival. This review will focus on the immunobiology of
the egg-associated granuloma elicited during S. mansoni infection
and will address the conundrum of the Schistosoma granuloma
eliciting inflammation that acts as both friend and foe during
infection.
THE IMMUNOPATHOGENESIS OF SCHISTOSOMAMANSONI
Humans become infected with S. mansoni following exposure to
water contaminated with skin penetrating cercariae. The S. man-
soni cercariae are highly motile organisms able to enter the host
via the penetration of intact skin. The cercariae transform into
schistosomula after entering the skin and migrate via the vascula-
ture and lymphatics through the lungs to the hepatic portal system.
Schistosomula differentiate to male and female schistosomes, pair,
and migrate to the mesenteric venous plexus, where adult worms
can live for 5–10 years. Female schistosomes produce ∼300 eggs
each day that are laid in mesenteric circulation. The eggs are viable,
metabolically active organisms, and are highly antigenic. S. man-
soni eggs adhere to the endothelium of mesenteric blood vessels
and evoke inflammation leading to a granulomatous response that
is necessary for translocation into the intestinal lumen and excre-
tion in the feces (DeFranco et al., 2007). Indeed eggs have been
shown to preferentially enter the Peyer’s patches within the intesti-
nal wall to facilitate egress of eggs to the intestinal lumen (Turner
et al., 2013). Eggs that pass through the intestinal wall are excreted
in the feces and if deposited in fresh water, may infect an appropri-
ate species of snail, thus propagating the life cycle. However, some
of the eggs may also become lodged in the host’s intestine, liver,
or other sites, where they can cause the morbidity and mortality
associated with schistosomiasis mansoni.
Clinical signs of schistosomiasis are dependent on the matura-
tion stage of parasites and their eggs. In humans, acute infection is
characterized by a debilitating febrile illness (Katayama fever) that
usually occurs before the appearance of eggs in the stool, having
a peak 6–8 weeks after infection. In chronic disease, eggs trapped
in various tissues evoke the formation of granulomatous inflam-
mation, which along with the ensuing fibrosis cause the majority
of pathological conditions. In individuals that develop HS, liver
portal tract fibrosis leads to obstructive vascular lesions, por-
tal hypertension, ascites, and fatal bleeding from esophagogastric
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varices. Collectively, granulomatous inflammation around para-
site eggs is a cardinal feature of schistosomiasis mansoni and the
egg-associated pathology is central to the morbidity and indeed
mortality that occurs in infected humans.
The use of animal models has facilitated the advancement of
our understanding of the immunopathology during S. mansoni
infection, with the mouse the most widely used species. It must be
stressed that S. mansoni infection of mice does not faithfully reca-
pitulate all aspects of human schistosomiasis (Fallon, 2000). Cru-
cially,mice do not appear to develop portal tract fibrosis (Symmers’
pipe stem fibrosis) that is associated with morbidity in humans,
instead pathology in mice is primarily associated with a granu-
lomatous responses to parasite eggs trapped in the host tissue,
primarily in the liver and intestines. Recently, an interesting caveat
to the use of inbred laboratory mouse strains was shown, with S.
mansoni infection of wild outbred mice leading to more marked
disease than inbred strains. The observed increased pathology in
outbred animals was specifically associated with interleukin (IL)-1
elicited IL-17 producing CD4+ T helper (Th)17 cells (Smith et al.,
2011). Nevertheless mouse studies, in particular, the recent use
of gene knockout or transgenic animals, has made fundamental
advances in understanding the mechanisms of immunopathology
of schistosomiasis.
Following infection of mice in the first 3–5 weeks, during which
the host is exposed to migrating immature parasites, there is
immune activation with a marked type 1 immune response, with
increased Th1 cells and release of IL-12 and interferon (IFN)-γ.
While the immune response during the initial weeks of infection
with S. mansoni is strongly type 1-mediated, and primarily tar-
geted against the worm antigens, it should be noted that type
2 responses are also primed. As the parasites mature, mate, and
begin to produce eggs after 5–6 weeks, the immune response alters
markedly alters, leading to a decrease in the type 1 immune com-
ponent and concomitant emergence of a potent type 2 response
(Pearce and MacDonald, 2002). The switch to a type 2-mediated
response from 5 to 6 weeks post infection is a consequence of
egg-production by mature female worms. S. mansoni eggs are
potent inducers of type 2 responses when injected into naive mice
(Vella et al., 1992). Furthermore, soluble egg-antigens (SEA) or
antigenic egg secretions also induced a marked type 2 response.
The egg-antigen stimulated type 2 response leads to Th2 cell
expansion, production of IL-4, IL-5, and IL-13 accompanied by
an upregulation in immunoglobulin (Ig) E levels and circulating
eosinophils. The peak of this type 2 response corresponds with the
maximal cell response against the egg and is closely associated with
the magnitude of granulomatous inflammation surrounding the
egg. During the chronic phase of infection, after∼3 months, there
is a marked decrease in the magnitude of the Th2 response and
a state of hyporesponsiveness emerges. The potential for the Th2
response to lead to controlled chronic disease is part of a dynamic
association between Th1, Th17, and T regulatory cells regulat-
ing disease severity during S. mansoni infection. For example,
intestinal-associated CD4+CD25+FoxP3+Tregs, which expand
during chronic, schistosome-induced colitic inflammation, are
capable of modulating Th2 via IL-4 suppression (Turner et al.,
2011). More relevantly, a similar Th/reg cytokine interplay may
also occur in man (Mbow et al., 2013).
IMMUNE DEPENDENCE OF GRANULOMA FORMATION
The classic phenomenon associated with S. mansoni infection
is the formation of multi-cellular granulomatous inflammation
surrounding eggs trapped in various tissues (Figure 1). The gran-
ulomatous response to the egg is primarily orchestrated by CD4+
T cells. However, CD8+ T cells, B cells, and M2 macrophages
have also been shown to play a role in regulating granuloma
formation (Fallon et al., 1998; Jankovic et al., 1998; Herbert
et al., 2004). In addition, eosinophils also form a prominent con-
stituent of the granuloma (Moore et al., 1977). However, while
marked eosinophil infiltration is a cardinal feature of the Schis-
tosoma granuloma (Lenzi et al., 1987), the actual function of
eosinophils in the granuloma is not known. The generation of
tissue eosinophilia during Schistosoma infection of mice is medi-
ated by type 2 cytokines, such as IL-5 and IL-13, (Sher et al.,
1990; Chiaramonte et al., 1999; Fallon et al., 2000; Reiman et al.,
2006). However, using two transgenic mouse strains deficient in
eosinophils, there was no marked defect in worm burden, granu-
loma formation, and liver fibrosis following S. mansoni infection
(Swartz et al., 2006). Further work is required to fully elucidate
FIGURE 1 | Representative histology sections (stained with H&E) of livers from a CD4+ T cell depleted (A) and normal (B) mouse, with arrows to
indicate the S. mansoni egg.
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the functions of eosinophils within the Schistosoma granuloma.
Similarly, while mast cells are also present within the Schistosoma
granuloma (Weinstock and Boros, 1983; Lenzi et al., 1987), the
actual involvement of such cells in the formation of the granuloma
around the egg and subsequent resolution is not known.
The importance of T cells in the generation of the granu-
loma was initially shown in nude mice and animals subjected
to T cell depletion; with T cell deficient mice having impaired
granuloma formation around eggs (Byram and von Lichtenberg,
1977; Doenhoff et al., 1981). A dominant role for CD4+ T cells
in granuloma formation was shown using depleting monoclonal
antibodies (Mathew and Boros, 1986; Fallon et al., 1998). While it
could be anticipated that the attenuated granuloma surrounding
the egg in CD4+ T cell-deficient mice would lead to less pathol-
ogy, the opposite occurred. Indeed there is striking mortality in
S. mansoni-infected mice with a compromised immune system
(Table 1). This highlights the paradox: the granuloma that forms
to encapsulates the egg can lead to pathology but the granuloma
also functions to protect the host.
S. mansoni infection of mice with CD4+ T cells depleted
develop an acute fatal disease, with animals dying from weeks
4–6 after infection; coincident with egg deposition in tissue (Fal-
lon et al., 1998). In immunologically intact mice, the eggs that are
deposited in the liver are encapsulated within the granuloma with
hepatocytes outside the granuloma are overtly normal (Figure 1),
with such mice having normal liver function. In contrast, in the
absence of CD4+ T cells there is a limited granulomatous response,
with the cellular infiltrate around the egg being neutrophil dom-
inated as opposed to the eosinophil-rich granuloma observed in
immunologically intact mice (Figure 2). Furthermore, without
an intact functional granuloma there is extensive microvesicular
damage to hepatocytes, and a consequential elevation in serum
transaminase levels consistent with hepatocyte damage. Grossly,
the hepatic steatosis is evident with the fat-laden white appearance
of the liver in immune suppressed infected mice (Figure 3).
Therefore formation of a granuloma around the egg can be
perceived as functioning to sequester egg secretions that can cause
hepatotoxicity (Dunne et al., 1991). In addition to liver specific
pathology, the absence of a functional granuloma in immune sup-
pressed mice also leads to an inability to efficiently excrete eggs
in feces, and consequentially eggs are trapped in the intestines
leading to inflammation. Indeed this phenomenon of immune
dependence of egg excretion (Doenhoff et al., 1981), illustrates
the novel usurping of immunity by the parasite whereby the egg
granuloma functions to induce a specific host immune response
resulting in the translocation of the egg through the intestinal wall
to be excreted in the feces. It is noteworthy that in other chronic
granulomatous diseases, specifically tuberculosis, it is suggested
that instead of limiting bacterial proliferation, the granuloma may
actually benefit the bacteria (Ramakrishnan, 2012).
Crucially, these experimental observations on a role for CD4+
T cells in facilitating egg excretion in S. mansoni-infected mice
also occur in humans. Karanja et al. examined egg excretion, i.e.,
detection of eggs in the feces, in a cohort of S. mansoni-infected
individuals in Kenya that were seronegative or seropositive for
human immunodeficiency virus (HIV). There was a positive asso-
ciation between egg excretion rates and levels of circulating CD4
in HIV+ patients, inferring a functional immune response was
needed for egg excretion in man (Karanja et al., 1997). This may be
S. mansoni specific phenomenon, or related to infection intensity,
as in another study in Zimbabwe there was no such association
between immune status and egg excretion in patients that were
predominately infected with S. haematobium (Kallestrup et al.,
2005).
The earlier studies in mouse models established an essential
role for CD4+ T cells in granuloma formation. More recently,
the role of Th1 cellular cytokines [such as Tumor Necrosis Fac-
tor (TNF)-α, IFN-γ, and IL-2], Th2 (such as IL-4, IL-5, IL-9,
and IL-13), Th17 (IL-17), and T regulatory cells in granuloma
formation have been elucidated (Singh et al., 2005; Rutitzky and
Stadecker, 2011). For example, mice deficient in type 1 cytokines
such as IFNγ and IL-12p40 show little alteration in pathology,
whilst mice deficient in certain type 2 cytokines are unable to gen-
erate a granuloma and may develop exacerbated pathology (Wynn
and Cheever, 1995). Thus IL-4 deficient mice have impaired gran-
uloma formation and develop acute fatal cachexia (Brunet et al.,
1997). Indeed in mice that are tolerized to egg-antigens, a type 1
biased response is evoked leading to hepatotoxicity and death (Fal-
lon and Dunne, 1999). Furthermore, in the absence of IL-4 alone,
or both IL-4 and IL-13, there is acute mortality with impaired
Table 1 | Summary of the consequence of S. mansoni egg infection in immunologically intact and immune compromised (e.g., CD4+ T cell
depleted) mice.
Liver Intestine Systemic
Gra Eob Fibrosis Hepatocyte
damage
Egg
excretion
Eob Pathology Antibody
responses
T cells Endotoxemia Mortalitiesc
(%)
Immunologically intact
mice
+ + + − + + − + Th2/Treg − <5
Immune compromised
mice
± − ± + − − + ± Th1/17 + 100
aGr, granulomatous inflammation.
bEo, tissue eosinophilia.
cMortalities are expressed as percentage (ranges) of mice dead by 56 days after an acute infection.
www.frontiersin.org April 2013 | Volume 4 | Article 89 | 3
Hams et al. The Schistosoma granuloma: friend or foe?
FIGURE 2 | Graphical representation of the cell populations involved in the formation of the S. mansoni egg-induced liver granuloma from an
immune suppressed (left ) and immunologically intact mouse (right ).
FIGURE 3 | Images of livers from an uninfected (A), an S. mansoni -infected immune competent (B), and immune suppressed (C) mouse. While an
infected immunologically intact mice has granulomas in the liver (B), in an immunodeficient mouse (C) there is marked whitening of the liver due to
microvesicular hepatosteatosis.
egg excretion leading to endotoxemia (Fallon et al., 2000). Thus
the generation of a functional granuloma is essential for a bal-
anced cellular immune response ensuring survival of mice during
infection with S. mansoni.
While a major focus has been on facets of adaptive immunity
contributing to the formation of the egg granuloma, in recent
years there is an increasing recognition that innate immunity also
contributes. The generation of type 2 immunity by schistosome
eggs requires antigen-presenting cells, such as dendritic cells (DC),
processing and presenting schistosome egg-antigens (MacDon-
ald et al., 2002). Indeed, depleting CD11c+ DCs during active
S. mansoni infection severely impairs Th2 responses, suggesting
that DCs are critical for Th2 induction (Phythian-Adams et al.,
2010). DCs are equipped with an array of pattern recognition
receptors (PRRs), including C-type lectin receptors (CLRs) and
Toll-like receptors (TLRs), in order to recognize and differenti-
ate between pathogens by binding pathogen-associated molecular
patterns (PAMPs) and instruct the immune system to mount a
dedicated response. In order to induce a Th2 response, SEA inter-
feres with TLR-mediated DC activation (Kane et al., 2004). SEA
can suppress maturation and cytokine production of human and
murine DCs induced by activation with the TLR4 ligand LPS and
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the TLR3 ligand poly-I:C (MacDonald et al., 2002; Kane et al.,
2004; van Liempt et al., 2007).
More recently, it has been shown that egg-antigens can also
activate the NLRP3 inflammasome, in combination with a TLR
agonist, leading to a release of IL-1β (Ritter et al., 2010). Such
inflammasome activation modulates the immune response during
Schistosoma infection, with mice deficient in NLRP3 developing
smaller and more fibrotic granulomas (Ritter et al., 2010). In
active infection it is feasible to conclude that TLR agonists such as
LPS may leak through the intestinal wall and associate with egg-
antigens to co-activate the inflammasome, leading to the release of
IL-1β, which is essential for schistosome-related immunomodula-
tion (Guo et al., 2009; Ritter et al., 2010). In this context it is rele-
vant that in mice strains that develop more severe disease during S.
mansoni infection, IL-1 receptor-associated kinase-like 2 (IRAK-
2) was identified as a novel regulator of IL-1-induced pathogenic
Th17 cells in schistosomiasis (Smith et al., 2011). The emergence of
the importance of the inflammasome in the generation of gran-
ulomatous inflammation highlights the vital role for the innate
immune response to the egg in generating the granuloma.
THE EGG GRANULOMA AND GENESIS OF FIBROSIS
A characteristic of S. mansoni infection is the development of
fibrosis within the portal tracts of man and in mice within the egg
granuloma. This pro-fibrotic property of the S. mansoni gran-
uloma was used to identify that IL-13 was the dominant Th2
cytokine responsible for the development of liver fibrosis. While
hepatic fibrosis is impaired in S. mansoni-infected mice unable
to signal through IL-4Rα (Il-4rα−/−), it is ablated in mice treated
with soluble IL-13Rα2-Fc and also fails to develop in mice deficient
in IL-13 (Il-13−/−) (Chiaramonte et al., 1999; Jankovic et al., 1999;
Fallon et al., 2000). In addition, in vitro studies have demonstrated
the ability of IL-13 to directly stimulate collagen production in
fibroblasts (Chiaramonte et al., 1999). The fibrogenic role of IL-13
involves the cytokine, together with IL-4, inducing the expression
of arginase in macrophages via M2 polarization. Arginase uses
l-arginine as a substrate to make l-ornithine, which is converted
by ornithine aminotransferase to proline, a crucial amino acid
for the production of collagen and the development of fibrosis
(Hesse et al., 2001). The major function of Arg-1 is to down-
modulate granulomatous inflammation in the liver and intestine
and to slow the progression of Th2-dependent fibrosis in chron-
ically infected mice (Pesce et al., 2009). The high expression of
Arg-1, Ym-1, and FIZZ1 in granulomatous tissue reflects the large
population of M2 macrophages and fibroblasts in the granuloma
(Hesse et al., 2001). The presence of M2 macrophages provides a
readily available supply of proline to the fibroblasts resulting in
collagen synthesis. Indeed IL-4Rα LysCre mice, which are defi-
cient in IL-4Rα specifically on macrophages and neutrophils, do
not develop M2 macrophages and following S. mansoni infections
there is endotoxemia and mortality of all infected mice (Herbert
et al., 2004). It should be noted, that seminal studies showing a role
for IL-13 in S. mansoni egg granulomatous fibrosis led to the eval-
uation of IL-13 as a therapeutic target in other fibrotic conditions
such as asthma (Kraft, 2011; Wynn and Ramalingam, 2012). In
addition to roles for cytokines chemokines are implicated in gran-
uloma formation (Chiu et al., 2003). Chemokines such as CCL2,
CCL3, CCL4, CCL7, CCL11, CCL12, and chemokine receptors
CCR1, CCR2, CCR3, and CCR4 have all been shown to be associ-
ated with an exacerbated disease in animal studies and have been
found at higher levels in the plasma or serum of schistosomiasis
patients (Souza et al., 2008).
S. MANSONI EGGS AND ASSOCIATED HEPATOTOXICITY
Whilst the egg granuloma is detrimental due to the inflammation
and associated fibrosis, the formation of the granuloma is essen-
tial in protecting the host from the toxins secreted by the egg. It
must be stressed that in mice the development of hepatotoxicity is
unique to S. mansoni infections, and is not seen in S. haematobium
or S. japonicum (Fallon, 2000). Antigens secreted by schistosome
eggs are potent inducers of the immune system and some are hepa-
totoxic, and if these antigens are not sequestered or neutralized the
resulting inflammatory response can cause lasting damage to the
host tissue (Dunne et al., 1981, 1991). As discussed above, along
with T cell-dependent antibodies, the granulomatous lesions act
to prevent these toxins reaching the hepatocytes (Figure 1).
Many aspects of the egg-induced immune response are medi-
ated by glycosylated SEA (Harn et al., 1989; Hokke and Yazdan-
bakhsh, 2005). SEA glycoproteins collectively display a very com-
plex set of glycans, comprising both specific schistosome glycans
and molecules expressed in the mammalian host also (Jang-Lee
et al., 2007). The ability of S. mansoni eggs to induce Th2 dif-
ferentiation during infection is underscored by the observation
that eggs-alone, or SEA released by the eggs through pores in the
shell, is sufficient to drive Th2 polarization in naïve uninfected
mice (Jankovic et al., 2004). A portion of SEA components are
excreted by the schistosome egg forming the excretory/secretory
(ES) fraction, while others come into contact with the host after
eggs die and release their soluble contents into the surrounding
tissue. Proteomic studies have shown that over a 1000 proteins
can be detected in SEA, with a broad range of functions on targets
located both inside (cytosolic and nuclear proteins) and outside
(membrane proteins, secretory proteins) the cell (Ashton et al.,
2001; Mathieson and Wilson, 2011). Distinctive glycan elements
abundantly present on SEA and ES glycoconjugates are recognized
by PRRs (Guo et al., 2004; Saunders et al., 2009; Ritter et al., 2010).
One well characterized Schistosoma egg glycan is the Lewis(X)-
containing lacto-N -fucopentaose III (LNFPIII), which has potent
immunomodulatory activity (Bhargava et al., 2012; Tundup et al.,
2012). In the context of defective granuloma formation leading to
microvesicular steatosis during infection (Figures 1 and 2), it is
interesting that LNFPIII has recently been shown to suppress liver
lipogenesis and protects against hepatosteatosis (Bhargava et al.,
2012; Tundup et al., 2012).
The most characterized egg secretions are derived from the
highly cationic egg fraction (CEF6) of the SEA containing two
important antigens, namely omega-1 (ω-1) and alpha-1 [α-1;
more recently termed IPSE (IL-4-inducing principle of S. man-
soni eggs) or S. mansoni chemokine binding protein (SmCKBP)].
Dunne et al. (1981) firstly formally characterized ω-1 and α-1.
Immunochemical characterization of ω-1 using sera from mice
and humans infected with different schistosome species clarified
this antigen as specific to S. mansoni (Dunne et al., 1991). ω-1 is
a 31 kDa monomeric glycoprotein, with a potent T2 ribonuclease
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(RNase) activity (Steinfelder et al., 2009) and is associated with
significant hepatotoxicity (Fitzsimmons et al., 2005). In addition,
transfer of antisera against ω-1 prevents hepatocyte damage in
S. mansoni-infected T cell depleted mice confirming the hepa-
totoxic effects of ω-1 (Dunne et al., 1991). Recently, it has been
hypothesized thatω-1 conditions mouse DCs to promote Th2 dif-
ferentiation via a mechanism involving mannose receptors, which
appear crucial for the efficient recognition and internalization of
ω-1 by DCs (Everts et al., 2012). Importantly, after translocation
into the cytosol, ω-1 programs DCs to drive a Th2 polarization
in an RNase-dependent manner by interfering with ribosomal
function and protein synthesis (Everts et al., 2012).
α-1 consists of two immunologically cross-reactive 41 and
36 kDa dimers, each of which consists of one unique and one
common glycoprotein subcomponent (Dunne et al., 1991). It is
particularly abundant in the sub-shell area of S. mansoni eggs from
where it is secreted into the surrounding tissue (Schramm et al.,
2003). α-1 binds Ig s and activates basophils, leading to histamine
release and facilitating the production of Th2 cytokines, in partic-
ular IL-4 (Schramm et al., 2007). It has been also demonstrated
that α-1 contains a functional C-terminal nuclear sequence that
binds DNA leading to a potential alteration in the gene expression
of the host cell (Kaur et al., 2011).
An immunomodulatory egg-antigen was identified during a
screen for CKBPs in antigen extracts from S. mansoni. An SmCKBP
was identified in SEA as a 36 kDa protein specifically secreted
by live S. mansoni eggs (Smith et al., 2005). Binding assays
showed that this egg-antigen specifically binds chemokines, such
as CXCL8, CCL3, and CX3CL1, CCL2, and CCL5. The secretion of
a CKBP by live schistosome eggs within the granuloma, suggests
that this antigen may block certain chemokines to facilitate granu-
loma formation and alter the cellularity of the granuloma (Smith
et al., 2005). As SmCKBP and α-1 are the same glycoprotein, it is
an example of a molecule that may orchestrate both the cellular
content and activation state of cells within the granuloma.
Collectively and paradoxically, while the eggs are the cause of
pathology during S. mansoni infection, they also afford some pro-
tection, acting to minimize collateral tissue damage in both the
liver and intestine. Therefore, even though the progression of a
granuloma into a fibrotic lesion can lead to death from portal
hypertension and hemorrhaging, ironically in the absence of a
granulomatous response, hepatic murine schistosomiasis results
in a more acute and lethal disease.
CONCLUSION
Although egg-induced granulomas are detrimental to the infected
host, it is clear that the inflammatory response also fulfills an
important host-protective function during S. mansoni infection.
The granuloma, rich in cells such as Th2 cells, eosinophils, and
M2 macrophages, acts to protect the surrounding host tissue from
the toxins released by the egg, not only by providing a physical
barrier between the egg and the tissue, but also by sequester-
ing the antigenic products secreted by the egg. This is of vital
importance, particularly in the liver due to the hepatotoxicity
associated with egg-antigens. However, the constant activation of
the immune system over time, in particular the type 2 immune
responses, results in excessive “wound healing” and invariably
leads to the development of fibrotic lesions in the place of the
granulomas.
While egg-associated granuloma formation clearly benefits the
host, it is also associated with pathology in infected individuals.
Conversely, the parasite uses the granuloma to facilitate excretion
of its eggs, without killing the host, to continue the life cycle. The
granuloma is thus both friend and foe during infection.
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